Valeant injects cash into bid for Botox maker-Reuters

Canadian drugmaker Valeant Pharmaceuticals International Inc raised the cash component of its unsolicited offer for Botox-maker Allergan Inc, valuing the U.S. firm at $49.44 billion (29.51 billion pounds) and ratcheting up pressure on the target company, Reuters reported.

DealsNorth AmericaUSBriefs